Skip to main content

Assetmark, Inc

Source: SEC Form 13F · as of Mar 2026

Assetmark, Inc holds 69 biotech & pharma companies tracked by BioSniper, totaling $287.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

69

Total value held

$287.0M

BioSniper AIPage evidence connected

Prepared research question

What matters most for EXELIXIS, INC. (EXEL)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
EXELEXELIXIS, INC.3,388,920$145.4M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)480,636$26.5M
SNYSanofi509,464$24.5M
GILDGILEAD SCIENCES, INC.136,538$19.0M
REGNREGENERON PHARMACEUTICALS, INC.12,316$9.5M
ONCBeOne Medicines Ltd.29,569$8.8M
ARGXARGENX SE9,275$6.8M
GMABGenmab A/S224,144$6.0M
INSMINSMED Inc34,258$5.6M
PTGXProtagonist Therapeutics, Inc46,442$4.9M
INVAInnoviva, Inc.205,072$4.8M
ALNYALNYLAM PHARMACEUTICALS, INC.14,207$4.7M
INCYIncyte Corp.42,597$4.0M
SUPNSUPERNUS PHARMACEUTICALS, INC.43,972$2.3M
JAZZJazz Pharmaceuticals plc11,366$2.1M
TEVATeva Pharmaceutical Industries Limited63,314$1.9M
BBIOBridgeBio Pharma, Inc.20,790$1.5M
LGNDLigand Pharmaceuticals Incorporated6,570$1.3M
BMRNBIOMARIN PHARMACEUTICAL INC22,875$1.3M
IMCRImmunocore Holdings plc28,387$856K
TERNTerns Pharmaceuticals, Inc.16,157$852K
COGTCogent Biosciences, Inc.18,987$731K
IONSIONIS PHARMACEUTICALS INC9,574$719K
TVTXTravere Therapeutics, Inc.19,636$583K
RDYDR REDDYS LABORATORIES LTD21,145$293K
QUREuniQure N.V.15,909$260K
CYTKCYTOKINETICS INC3,463$228K
AXSMAxsome Therapeutics, Inc.1,182$200K
ARWRARROWHEAD PHARMACEUTICALS, INC.2,470$155K
BHVNBiohaven Ltd.17,073$144K
VKTXViking Therapeutics, Inc.3,870$126K
GPCRStructure Therapeutics Inc.2,544$123K
PCVXVaxcyte, Inc.1,879$109K
DNLIDenali Therapeutics Inc.5,199$100K
ABVXAbivax SA886$99K
ALMSALUMIS INC.4,188$92K
ADPTAdaptive Biotechnologies Corp4,421$61K
AGIOAGIOS PHARMACEUTICALS, INC.1,317$45K
MRNAModerna, Inc.801$41K
ORICOric Pharmaceuticals, Inc.3,000$38K
ARQTArcutis Biotherapeutics, Inc.1,517$36K
BCYCBICYCLE THERAPEUTICS PLC4,218$20K
RVMDREVOLUTION MEDICINES, INC.185$18K
NUVLNuvalent, Inc.57$6K
ROIVRoivant Sciences Ltd.197$5K
ACADACADIA PHARMACEUTICALS INC245$5K
TGTXTG THERAPEUTICS, INC.115$4K
IMVTImmunovant, Inc.117$3K
HCMHUTCHMED (China) Limited187$3K
ANABANAPTYSBIO, INC36$2K
TLXTelix Pharmaceuticals Limited153$1K
FBRXForte Biosciences, Inc.46$1K
ANIPANI PHARMACEUTICALS INC11$846
IRONDisc Medicine, Inc.12$767
CLDXCelldex Therapeutics, Inc.21$666
IOVAIOVANCE BIOTHERAPEUTICS, INC.183$642
GRFSGrifols S.A.75$602
GERNGERON CORP335$499
VCELVericel Corp15$483
RNAAtrium Therapeutics Inc.34$455
NTLAIntellia Therapeutics, Inc.33$423
CTXRCitius Pharmaceuticals, Inc.372$335
KNSAKiniksa Pharmaceuticals International, plc5$241
PTCTPTC THERAPEUTICS, INC.3$204
OGNOrganon & Co.22$134
PHIOPhio Pharmaceuticals Corp.110$134
TNXPTonix Pharmaceuticals Holding Corp.3$41
JBIOJade Biosciences, Inc.1$14
IBRXImmunityBio, Inc.1$8

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.